Ramirez, Larabel .
HRN: 15-88-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2024
METRONIDAZOLE 500MG (TAB)
01/31/2024
02/07/2024
PO
500mg
TID X 7 Days
Thickly MSAF; RMLE And Repair
Waiting Final Action
Indication: ProphylaxisEmpiricEmpirical De-escalation Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes